The two first authors contributed equally to this article.
Original Article
Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia†‡
A Study From the Acute Leukemia French Association
Article first published online: 17 JUN 2009
DOI: 10.1002/cncr.24442
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Renneville, A., Boissel, N., Zurawski, V., Llopis, L., Biggio, V., Nibourel, O., Philippe, N., Thomas, X., Dombret, H. and Preudhomme, C. (2009), Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia. Cancer, 115: 3719–3727. doi: 10.1002/cncr.24442
- †
We thank all patients and members of the Acute Leukemia French Association for their participation.
- ‡
The following additional members of the Acute Leukemia French Association (ALFA) contributed to this work: Sandrine Hayette, MD (Department of Cytogenetics and Molecular Biology, Edouard Herriot Hospital, Lyon, France) Stéphane de Botton, MD, PhD (Gustave Roussy Institute, Villejuif, France) Jean-Michel Cayuela, MD, PhD (Department of Hematology, St. Louis Hospital, Paris, France) Dominique Bories, MD (Department of Hematology, Henri Mondor Hospital, Créteil, France); Xavier Troussard, MD (Department of Hematology, Caen Hospital, Caen, France); Christine Terré, MD (Department of Cytogenetics, André Mignot Hospital, Versailles, France); and Sylvie Castaigne, MD (Department of Hematology and Oncology, André Mignot Hospital, Versailles, France).
Publication History
- Issue published online: 3 AUG 2009
- Article first published online: 17 JUN 2009
- Manuscript Accepted: 22 JAN 2009
- Manuscript Revised: 19 JAN 2009
- Manuscript Received: 4 SEP 2008
Funded by
- Fondation de France (Leukemia Committee)
- North-West Canceropole (Onco-Hematology Axis)
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association, American Journal of Hematology, 2012, 87, 1Direct Link:
- 2, , , , , , , , , , , , , , , , , , , , Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association, Leukemia, 2012,
- 3, , , , , , , , , , WT1mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population, Leukemia & Lymphoma, 2012, 1
- 4, , Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia, Hematology/Oncology Clinics of North America, 2011, 25, 6, 1135
- 5, , , , FLT3 inhibitors in the treatment of acute myeloid leukemia, Cancer, 2011, 117, 15Direct Link:
- 6, , , , , , , , Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group, Pediatric Blood & Cancer, 2011, 57, 2Direct Link:
- 7, , , , Molecular analysis ofWT1andKITmutations in patients from an Indian population withde novoacute myeloid leukemia: determination of incidence, distribution patterns, and report of a novelKITmutation, Leukemia & Lymphoma, 2011, 52, 5, 865
- 8, , , , , , , , , , , , , Single nucleotide polymorphism of Wilmsâ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia, Annals of Hematology, 2011, 91, 5, 671
- 9, , , , , , , , , , , , , , Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia, Leukemia, 2011, 25, 12, 1918
- 10, , , Molecular genetics in acute myeloid leukemia, Current Opinion in Oncology, 2010, 22, 6, 646
- 11, , , , , , , , , , , , , , , , , , , , , Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study, Blood, 2010, 116, 5, 788
- 12, , Older patients with acute myeloid leukemia, Expert Review of Hematology, 2010, 3, 6, 755
- 13, , , , , , , , , , , , , Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group, Blood, 2010, 116, 5, 702
- 14, , , The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia, Hematological Oncology, 2010, 28, 1Direct Link:
- 15, , , , , , , , , , , , , , , , , , , , WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system, Blood, 2010, 115, 25, 5222
- 16, , , , , , , , , , , , , , , , , , , Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, 2009, 115, 3, 453
- 17
- 18, , , , , , , , , , , , Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies, Leukemia, 2009, 24, 2, 476

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)